These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30084727)
1. Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Li Y; Duo Y; Zhai P; He L; Zhong K; Zhang Y; Huang K; Luo J; Zhang H; Yu X Nanomedicine (Lond); 2018 Jul; 13(14):1753-1772. PubMed ID: 30084727 [No Abstract] [Full Text] [Related]
2. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer. Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364 [TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Li Y; Duo Y; Bi J; Zeng X; Mei L; Bao S; He L; Shan A; Zhang Y; Yu X Int J Nanomedicine; 2018; 13():1241-1256. PubMed ID: 29535520 [TBL] [Abstract][Full Text] [Related]
4. CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy. Duo Y; Yang M; Du Z; Feng C; Xing C; Wu Y; Xie Z; Zhang F; Huang L; Zeng X; Chen H Acta Biomater; 2018 Oct; 79():317-330. PubMed ID: 30172068 [TBL] [Abstract][Full Text] [Related]
5. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells. Kamil Mohammad Al-Mosawi A; Bahrami AR; Nekooei S; Saljooghi AS; Matin MM Front Bioeng Biotechnol; 2022; 10():1095837. PubMed ID: 36686226 [No Abstract] [Full Text] [Related]
6. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents. Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677 [TBL] [Abstract][Full Text] [Related]
7. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
8. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731 [TBL] [Abstract][Full Text] [Related]
9. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
10. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy. Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Lee JE; Lee N; Kim T; Kim J; Hyeon T Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274 [TBL] [Abstract][Full Text] [Related]
12. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells. Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225 [TBL] [Abstract][Full Text] [Related]
13. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786 [TBL] [Abstract][Full Text] [Related]
14. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles. Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819 [TBL] [Abstract][Full Text] [Related]
16. MMP-responsive theranostic nanoplatform based on mesoporous silica nanoparticles for tumor imaging and targeted drug delivery. Hu JJ; Liu LH; Li ZY; Zhuo RX; Zhang XZ J Mater Chem B; 2016 Mar; 4(11):1932-1940. PubMed ID: 32263070 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227 [TBL] [Abstract][Full Text] [Related]
18. Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics. Abrishami A; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM Commun Biol; 2024 Apr; 7(1):393. PubMed ID: 38561432 [TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047 [No Abstract] [Full Text] [Related] [Next] [New Search]